Cancer is the deadliest disease of all, regardless of the type of malignancy. Millions of people worldwide die every year of cancer. The early detection of cancer increases the patient's chances of survival significantly. Unfortunately, most of the cancer patients are diagnosed in the final stages of the disease. In later stages, the tumor has spread tremendously, leaving no better treatment options for either stopping the metastasis or complete removal of cancer. Recently, artificial intelligence and deep learning have shown major significance in solving this issue. Accordingly, this book focuses on using artificial intelligence techniques for diagnosing lung and kidney cancer. It's main aim is to help advance scientific research within the field. The book focuses on major trends and challenges in this area, and it presents work aimed to identify new techniques and their use in biomedical analysis.
Reihe
Sprache
Verlagsort
Zielgruppe
Illustrationen
With figures in colour and black and white; 74 Illustrations
ISBN-13
978-0-7503-3603-1 (9780750336031)
DOI
10.1088/978-0-7503-3603-1
Copyright in bibliographic data and cover images is held by Nielsen Book Services Limited or by the publishers or by their respective licensors: all rights reserved.
Schweitzer Klassifikation
Ayman El-Baz is Chair, Department of Bioengineering at the University of Louisville and a Distinguished Scholar. Dr. El-Baz earned his B.Sc. and M.Sc. degrees in electrical engineering in 1997 and 2001, respectively. He earned his Ph.D. in electrical engineering from the University of Louisville in 2006. Dr. El-Baz was named as a Fellow for Coulter, AIMBE and NAI for his contributions to the field of biomedical translational research. Dr. El-Baz has almost two decades of hands-on experience in the fields of bio-imaging modeling and non-invasive computer-assisted diagnosis systems. He has authored or co-authored more than 500 technical articles (182 journals, 44 books, 95 book chapters, 253 refereed-conference papers, 215 abstracts, and 38 US patents and Disclosures).
Jasjit S. Suri is an innovator, scientist, visionary, industrialist and an internationally known world leader in biomedical engineering. Dr. Suri has spent over 25 years in the field of biomedical engineering/devices and its management. He received his Ph.D. from the University of Washington, Seattle and his Business Management Sciences degree from Case Western Reserve University, Cleveland, Ohio. Dr. Suri received the President's Gold medal in 1980 and made Fellow of the American Institute of Medical and Biological Engineering for his outstanding contributions. In 2018, he was awarded the Marquis Life Time Achievement Award for his outstanding contributions and dedication to medical imaging and its management .
Herausgeber*in
University of Lousiville, USA
The American Institute for Medical and Biological Engineering, USA
